It was demonstrated that MYC preferentially triggers transformation of the most immature MSI2+ pancreas cells into multi-lineage pre-cancer cells, which diverge to establish pancreatic cancer subtypes by activating distinct transcriptional programs and large-scale genomic changes. This evidence concerns the gene MSI2 and familial pancreatic carcinoma.